111 related articles for article (PubMed ID: 29600373)
1. Targeted Single Gene Mutation in Esophageal Adenocarcinoma.
Lee KTW; Smith RA; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():213-229. PubMed ID: 29600373
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics: DNA Methylation Analysis in Esophageal Adenocarcinoma.
Islam F; Tang JC; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():247-256. PubMed ID: 29600375
[TBL] [Abstract][Full Text] [Related]
3. Somatic DNA Copy-Number Alterations Detection for Esophageal Adenocarcinoma Using Digital Polymerase Chain Reaction.
Lee KTW; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():195-212. PubMed ID: 29600372
[TBL] [Abstract][Full Text] [Related]
4. DNA Genome Sequencing in Esophageal Adenocarcinoma.
Pillai S; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():231-246. PubMed ID: 29600374
[TBL] [Abstract][Full Text] [Related]
5. Molecular clonality analysis of esophageal adenocarcinoma by multiregion sequencing of tumor samples.
van Nistelrooij AM; van Marion R; Koppert LB; Biermann K; Spaander MC; Tilanus HW; van Lanschot JJ; Wijnhoven BP; Dinjens WN
BMC Res Notes; 2017 Apr; 10(1):144. PubMed ID: 28376920
[TBL] [Abstract][Full Text] [Related]
6. Targeted next-generation sequencing of commonly mutated genes in esophageal adenocarcinoma patients with long-term survival.
Visser E; Franken IA; Brosens LAA; de Leng WWJ; Strengman E; Offerhaus JA; Ruurda JP; van Hillegersberg R
Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859360
[TBL] [Abstract][Full Text] [Related]
7. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy for Investigation of Cancer DNA in Esophageal Adenocarcinoma: Cell-Free Plasma DNA and Exosome-Associated DNA.
Smith RA; Lam AK
Methods Mol Biol; 2018; 1756():187-194. PubMed ID: 29600371
[TBL] [Abstract][Full Text] [Related]
9. mdm-2 expression correlates with wild-type p53 status in esophageal adenocarcinoma.
Soslow RA; Altorki NK; Yang G; Xie D; Yang CS
Mod Pathol; 1999 Jun; 12(6):580-6. PubMed ID: 10392633
[TBL] [Abstract][Full Text] [Related]
10. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
[TBL] [Abstract][Full Text] [Related]
12. p53 Mutations in carcinoma of the esophagus and gastroesophageal junction.
Sengpiel C; König IR; Rades D; Noack F; Duchrow M; Schild SE; Ludwig D; Homann N
Cancer Invest; 2009 Jan; 27(1):96-104. PubMed ID: 19160092
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
[TBL] [Abstract][Full Text] [Related]
14. Targeted Sequencing of Sorted Esophageal Adenocarcinoma Cells Unveils Known and Novel Mutations in the Separated Subpopulations.
Isidori F; Bozzarelli I; Mastracci L; Malvi D; Lugaresi M; Molinari C; Söderström H; Räsänen J; D'Errico A; Fiocca R; Seri M; Krishnadath KK; Bonora E; Mattioli S
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00202. PubMed ID: 33094962
[TBL] [Abstract][Full Text] [Related]
15. TP53 gene mutations are rare in nondysplastic Barrett's esophagus.
Novotna K; Trkova M; Pazdro A; Smejkal M; Soukupova A; Kodetova D; Smejkal P; Sedlacek Z
Dig Dis Sci; 2006 Jan; 51(1):110-3. PubMed ID: 16416221
[TBL] [Abstract][Full Text] [Related]
16. Biobanking of fresh-frozen endoscopic biopsy specimens from esophageal adenocarcinoma.
Stiekema J; Cats A; Boot H; Langers AM; Balague Ponz O; van Velthuysen ML; Braaf LM; Nieuwland M; van Sandick JW
Dis Esophagus; 2016 Nov; 29(8):1100-1106. PubMed ID: 26541751
[TBL] [Abstract][Full Text] [Related]
17. Detection and Quantification of MicroRNAs in Esophageal Adenocarcinoma.
Amin M; Islam F; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():257-268. PubMed ID: 29600376
[TBL] [Abstract][Full Text] [Related]
18. [Frequency and significance of APC gene mutations in malignant degeneration of Barrett esophagus].
Stöltzing O; Schneider PM; Becker K; Wegerer S; Siewert JR; Hölscher AH
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):485-9. PubMed ID: 14518303
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma.
Baumann S; Keller G; Pühringer F; Napieralski R; Feith M; Langer R; Höfler H; Stein HJ; Sarbia M
Int J Cancer; 2006 Jul; 119(2):264-8. PubMed ID: 16477636
[TBL] [Abstract][Full Text] [Related]
20. Barrett's: do we still need goblet cells for diagnosis?
Lenglinger J; Riegler M
Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
[No Abstract] [Full Text] [Related]
[Next] [New Search]
